Forte Biosciences (FBRX) Current Deferred Revenue (2016 - 2019)
Forte Biosciences (FBRX) reported Current Deferred Revenue of $9000.0 for Q3 2019, down 75.0% year-over-year from $36000.0 in Q3 2018, and down 50.0% quarter-over-quarter from $18000.0 in Q2 2019.
Forte Biosciences (FBRX) Current Deferred Revenue (2016 - 2019) Analysis & Trends
Forte Biosciences (FBRX) has 4 years of Current Deferred Revenue data on file, last reported at $9000.0 in Q3 2019.
- Current Deferred Revenue for Q3 2019 came in at $9000.0, down 75.0% year-over-year; the trailing twelve-month figure through Sep 2019 was $9000.0 (down 75.0% YoY), and the FY2018 annual result was $36000.0, changed 0.0% from the prior year.
- Current Deferred Revenue declined to $9000.0 in Q3 2019 per FBRX's latest filing, from $18000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $1.0 million in Q2 2018 and troughed at $9000.0 in Q3 2019.
- A 4-year average of $116833.3 and a median of $36000.0 in 2017 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2018 and 2019: Current Deferred Revenue soared 2426.83% in 2018, then plunged 98.26% in 2019.
- A 4-year view of Current Deferred Revenue shows it stood at $45000.0 in 2016, then decreased by 20.0% to $36000.0 in 2017, then changed by 0.0% to $36000.0 in 2018, then sank by 75.0% to $9000.0 in 2019.
- Business Quant data shows FBRX's Current Deferred Revenue at $9000.0 in Q3 2019, $18000.0 in Q2 2019, and $27000.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Forte Biosciences | 70.77 Mn | 12.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 9,000.00 |
| Jun 30, 2019 | 18,000.00 |
| Mar 31, 2019 | 27,000.00 |
| Dec 31, 2018 | 36,000.00 |
| Sep 30, 2018 | 36,000.00 |
| Jun 30, 2018 | 1.04 Mn |
| Mar 31, 2018 | 36,000.00 |
| Dec 31, 2017 | 36,000.00 |
| Sep 30, 2017 | 41,000.00 |
| Jun 30, 2017 | 41,000.00 |
| Mar 31, 2017 | 41,000.00 |
| Dec 31, 2016 | 45,000.00 |